Current Edition

Focus should be on public health and patient safety after EMA relocation decision, says Brexit Health Alliance

Responding to the announcement about the new location of the European Medicines Agency (EMA), Niall Dickson, co-chair of the Brexit Health Alliance, said: “The Brexit Health Alliance would like to congratulate Amsterdam on its successful bid to host the EMA.”
“This decision means the focus should now turn to how effective public health and patient safety can be upheld during this change and for the future. The emphasis must now be on finding transitional and post-Brexit agreement for the UK and EU to work together on medicines’ safety, regulation and supply”, added Dickson.
The Brexit Health Alliance brings together the NHS, medical research, industry, patients and public health organisations to safeguard the interests of patients and the healthcare and research they rely on as the UK moves into negotiations with the EU.
The Brexit Health Alliance will complement the work of the Cavendish Coalition, which is concerned with the staffing and workforce implications in health and social care of the UK leaving the EU. The Cavendish Coalition is led by NHS Employers, which is part of the NHS Confederation.
For more information, visit